The abstract is read at the publisher; the summary is JClub's.
Psychiatric biomarker research faces a validation bottleneck that blocks clinical integration, limiting routine use despite ongoing discovery efforts.
- Why it matters: The field struggles to bridge the gap between identifying candidate biomarkers and proving they work reliably in clinical settings.
- What they did: This Viewpoint proposes collaborative, translation-focused steps to move biomarker findings from discovery toward routine psychiatric care.
- The result: Coordinated validation and implementation efforts are suggested to enable clinical integration of psychiatric biomarkers into everyday practice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.